Keyword: UC San Francisco
The week’s biotech discoveries include an insulin-related gene mutation and the news that previously ignored brain structures could govern obesity.
Scientists at the University of California, San Francisco are recreating early development, then leaving it up to cells to fold themselves into complex human tissues.
A new form of CRISPR/Cas9 activates specific genes without making breaks in the DNA, which can reduce harmful side effects.
UCSF scientists are testing a therapeutic vaccine that can prompt the immune system to launch an attack against a cancer.
The past week brought new insights into how beige fat cells burn glucose, a particular protein foretells Alzheimer's and bacteria evade antibiotics.
The past week saw news of a partnership aimed at improving cancer discovery, a technique for reversing heart damage and a new cancer-killing cell.
UC Berkeley scientists are using a new CRISPR delivery system to more safely correct the mutated dystrophin gene in mouse models of DMD.
The past week brought news of discoveries in neuroblastoma, type 1 diabetes and multiple sclerosis.
The financing gives Laura Deming, who started work on the fund before turning 18, $22 million to invest in companies working on age-related diseases.
Sean Parker’s immuno-oncology institute has allied with Tessa Therapeutics to turn T-cell therapies against solid tumors.